INTERVIEW: Dr. Reddy’s COO On Derma Build Up, Biologics Norms
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories (DRL) appears to be building on plans for its differentiated dermatology and neurology formulations in the US after gains on the approvals front.